多学科诊治重症急性胰腺炎合并四肢肌无力
摘要
<正>重症急性胰腺炎(severe acute pancreatitis,SAP)是一种病情凶险、并发症复杂、病死率高,需要多学科处理的消化系统疾病。SAP常合并的全身并发症包括多器官功能衰竭(multiple organ dysfunction syn-drome,MODS)、脓毒症、腹腔出血、消化道瘘、门静脉血栓等,引起肌肉系统障碍病案较少,且原因不明。现介绍一例我院重症医学中心收治的SAP合并严重肌无力病例,系统阐述引起肌无力的可能病因与病理机制,以期为此类疾病的及时诊治提供
引文
[1]Yuki N,Hartung HP.Guillain-Barre syndrome[J].N Engl JMed,2012,366(24):2294-2304.
[2]Vellozzi C,Iqbal S,Broder K.Guillain-Barre syndrome,influenza,and influenza vaccination:the epidemiologic evidence[J].Clin Infect Dis,2014,58(8):1149-1155.
[3]Bailey EE,Fiorentino DF.Amyopathic dermatomyositis:definitions,diagnosis,and management[J].Curr Rheumatol Rep2014,16(12):465.
[4]Findlay AR,Goyal NA,Mozaffar T.An overview of polymyositis and dermatomyositis[J].Muscle Nerve 2015,51(5):638-656.
[5]Zutt R,van der Kooi AJ,Linthorst GE,et al.Rhabdomyolysis:review of the literature[J].Neuromuscul Disord,2014,24(8):651-659.
[6]Chatzizisis YS,Misirli G,Hatzitolios AI,et al.The syndrome of rhabdomyolysis:complications and treatment[J].Eur J Intern Med,2008,19(8):568-574.
[7]Petejova N,Martinek A.Acute kidney injury due to rhabdomyolysis and renal replacement therapy:a critical review[J].Crit Care(London,England),2014,18(3):224.
[8]Nadeau JO,Bhibhatbhan A,McDougall D,et al.Identification and comparison of adverse events for preparations of IVIG in patients with neuromuscular diseases[J].Clin Neurol Neurosurg2010,112(6):467-469.
[9]Osias J,Manno E.Neuromuscular complications of critical illness[J].Crit Care Clin,2014,30(4):785-794.
[10]Jackson MJ,Jones DA,Edwards RH.Measurements of calcium and other elements in muscle biopsy samples from patients with Duchenne muscular dystrophy[J].Clin Chimica Acta,1985,147(3):215-221.
[11]Lacomis D,Petrella JT,Giuliani MJ.Causes of neuromuscular weakness in the intensive care unit:a study of ninety-two patients[J].Muscle Nerve,1998,21(5):610-617.
[12]Chambers MA,Moylan JS,Reid MB.Physical inactivity and muscle weakness in the critically ill[J].Crit Care Med,2009,37(10 Suppl):S337-346.
[2]Vellozzi C,Iqbal S,Broder K.Guillain-Barre syndrome,influenza,and influenza vaccination:the epidemiologic evidence[J].Clin Infect Dis,2014,58(8):1149-1155.
[3]Bailey EE,Fiorentino DF.Amyopathic dermatomyositis:definitions,diagnosis,and management[J].Curr Rheumatol Rep2014,16(12):465.
[4]Findlay AR,Goyal NA,Mozaffar T.An overview of polymyositis and dermatomyositis[J].Muscle Nerve 2015,51(5):638-656.
[5]Zutt R,van der Kooi AJ,Linthorst GE,et al.Rhabdomyolysis:review of the literature[J].Neuromuscul Disord,2014,24(8):651-659.
[6]Chatzizisis YS,Misirli G,Hatzitolios AI,et al.The syndrome of rhabdomyolysis:complications and treatment[J].Eur J Intern Med,2008,19(8):568-574.
[7]Petejova N,Martinek A.Acute kidney injury due to rhabdomyolysis and renal replacement therapy:a critical review[J].Crit Care(London,England),2014,18(3):224.
[8]Nadeau JO,Bhibhatbhan A,McDougall D,et al.Identification and comparison of adverse events for preparations of IVIG in patients with neuromuscular diseases[J].Clin Neurol Neurosurg2010,112(6):467-469.
[9]Osias J,Manno E.Neuromuscular complications of critical illness[J].Crit Care Clin,2014,30(4):785-794.
[10]Jackson MJ,Jones DA,Edwards RH.Measurements of calcium and other elements in muscle biopsy samples from patients with Duchenne muscular dystrophy[J].Clin Chimica Acta,1985,147(3):215-221.
[11]Lacomis D,Petrella JT,Giuliani MJ.Causes of neuromuscular weakness in the intensive care unit:a study of ninety-two patients[J].Muscle Nerve,1998,21(5):610-617.
[12]Chambers MA,Moylan JS,Reid MB.Physical inactivity and muscle weakness in the critically ill[J].Crit Care Med,2009,37(10 Suppl):S337-346.